Heterogenous and compartment-specific activation of nonlymphocytic, mononuclear cells in intra-abdominal sepsis

Experimental Lung Research

Volumn 29, Issue 7, 2003, Pages 503-521

  Wang, C ^a   Kuzma, M ^a   Qiu, G ^a   Yin, K ^a  

^a UMDNJ School of Osteopathic Medicine   (United States)

Author keywords

Cytokines; Lung; Macrophages; Phagocytosis

Indexed keywords

LACTATE DEHYDROGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COMPARTMENTALIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; EVALUATION; LIGATION; LUNG ALVEOLUS; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; LUNG LAVAGE; LYMPHOCYTE ACTIVATION; MALE; MEASUREMENT; MEDIATOR RELEASE; MONONUCLEAR CELL; NONHUMAN; PERITONEAL CAVITY; PERITONITIS; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; RAT STRAIN; SEPSIS;

ANIMALS; BODY FLUID COMPARTMENTS; BRONCHOALVEOLAR LAVAGE FLUID; CECUM; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; LUNG; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; NITRIC OXIDE; PERITONEAL CAVITY; PERITONITIS; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS;

EID: 0141889960     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/01902140303779     Document Type: Article

References (34)

1. Rinaldo JE, Christman JW: Mechanisms and mediator of the adult respiratory distress syndrome. Clin Chest Med. 1990;11:621-632.
2. Demling RH: Current concepts on the adult respiratory distress syndrome. Circ Shock. 1990;30:297-309.
3. Faist E, Markewitz A, Fuchs D, Lang S, Zarius S, Schildberg FW, Wachter H, Reichart B: Immunomodulatory therapy with thymopentin and indomethacin. Successful restoration of interleukin-2 synthesis in patients undergoing major surgery. Ann Surg. 1991;214:264-275.
4. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM: Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest. 1991;88:1747-1754.
5. Reddy RC, Chen GH, Newstead MW, Moore T, Zeng X, Tateda K, Standiford TJ: Alveolar macrophage deactivation in murine septic peritonitis: role of interleukin-10. Infect Immun. 2001;69:1394-1401.
6. Steinhauser ML, Hogaboam CM, Kunkel SL, Lukacs NW, Stricter RM, Standiford TJ: IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J Immunol. 1999;162:392-399.
7. Munford RS, Pugin J: Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med. 2001;163:316-321.
8. Fliegert FG, Tschernig T, Pabst R: Comparison of lymphocyte subsets, monocytes and NK cells in three different lung compartments and peripheral blood in the rat. Exp Lung Res. 1996;22:677-690.
9. Schuster M, Tschernig T, Klug N, Pabst R: Lymphocytes migrate from the blood into the bronchoalveolar lavage and lung parenchyma in the asthma model of the brown norway rat. Am J Respir Crit Care Med. 2000;161:558-566.
10. Pabst R, Binns M, Licence ST, Peter M: Evidence of a selective major vascular marginal pool of lymphocytes in the lung. Am Rev Respir Dis. 1987;136:1213-1218.
11. Eisenstein TK: Implications of salmonella-induced nitric oxide (NO) for host defense and vaccines: NO, an antimicrobial, antitumor, immunosuppressive and immunoregulatory molecule. Micobes Infect. 2001;3:1223-1231.
12. Wang le F, Patel M, Razavi HM, Weicker S, Joseph MG, McCormack DG, Mehta S: Role of inducible nitric oxide synthase in pulmonary microvascular protein leak in murine sepsis. Am J Respir Crit Care Med. 2002;165:1634-1639.
13. Trichieri G: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann Rev Immunol. 1995;13:251-276.
14. Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Strieter RM, Kunkel SL: Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: crosstalk between MCP-1 and leukotriene B4. J Immunol. 1999;163:6148-6154.
15. Chaudry IH, Wichterman KA, Baue AE: Effect of sepsis on tissue adenine nucleotide levels. Surgery. 1979;85:205-211.
16. Mercer-Jones MA, Heinzelman M, Peyton JC, Wickel D, Cook M, Cheadle WG: The pulmonary inflammatory response to experimental fecal peritonitis: relative roles of tumor necrosis factor-α and endotoxin. Inflammation. 1997;21:401-417.
17. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shock: a review of laboratory models and a proposal. J Surg Res. 1980;29:189-201.
18. Seki S, Osada S-I, Ono S, Aosasa S, Habu Y, Nishikage T, Mochizuki H, Hiraide H: Role of liver NK cells and peritoneal macrophages in gamma interferon and interleukin-10 production in experimental bacterial peritonitis in mice. Infect Immun. 1998;66:5286-5294.
19. Yin K, Hock CE, Lai P-S, Ross J-T, Yue G: Role of interferon-gamma in lung inflammation following cecal ligation and puncture in rats. Shock. 1999;12:215-221.
20. Meldrum DR, McIntyre RC Jr, Sheridan BC, Cleveland JC Jr, Fullerton DA, Harken AH: L-Arginine decreases alveolar macrophage proinflammatory monokine production during acute lung injury by a nitric oxide synthase-dependent mechanism. J Trauma. 1997;43:888-893.
21. Kubes PM, Kurose I, Granger DN. NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. Am J Physiol. 1994;267:H931-H937.
22. Nathan CF, Hibbs JB: Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol. 1991;3:65-70.
23. Szabo C: The pathophysiological role of peroxynitrite in shock, inflammation and ischemia-reperfusion injury. Shock. 1996;7:235-246.
24. Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA: Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor. J Immunol. 1992;149:1666-1670.
25. Silva AT, Cohen J: Role of interferon-γ in experimental gram-negative sepsis. J Infect Dis. 1992;166:331-335.
26. Gallin JI, Farber JM, Holland SM, Nutman TB: Interferon-(gamma) in the management of infectious diseases. Ann Intern Med. 1995;123:216-224.
27. Ayala A, Perrin MM, Kisala JM, Ertel W, Chaudry IH: Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukins-1 and -6 and tumor necrosis factor). Circ Shock. 1992;36:191-199.
28. Chensue SW, Warmington KS, Ruth JH, Sanghi PS, Lincoln P, Kunkel SL: Role of monocyte chemoattractant protein-1 (MCP-1) in TH1 (mycobacterial) and TH2 (schistosomal) antigen-induced granuloma formation. J Immunol. 1996;157:4602-4608.
29. Leonard EJ, Yoshimura T: Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today. 1990;11:97-101.
30. Jiang Y, Beller DI, Frendl G, Graves DT: Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol. 1992;148:2423-2428.
31. Bossink AW, Paemen L, Jansen PM, Hack CE, Thijs LG, Damme JV: Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood. 1995;86:3841-3847.
32. Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, Kunkel SL, Walz A, Hudson LD, Martin TR: Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1996;154:602-611.
33. Nakano Y, Kasahara T, Mukaida N, Ko YC, Nakano M, Matsushima K: Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor. Infect Immun. 1994;62:377-383.
34. Zisman DA, Kunkel SL, Strieter RM, Tsai WC, Bucknell K, Wilkowski J, Standiford TJ: MCP-1 protects mice in lethal endotoxemia. J Clin Invest. 1997;99:2832-2836.